Tag / Kindai University
Immuno-pathogenesis of Chronic Pancreatic Diseases Uncovered Applications expected for the treatment of pancreatic diseases and preventive measures for pancreatic cancer - Kindai University
Press Releases • Oct 25, 2018 16:00 GMT
Until now, the barely understood immuno-pathogenesis for chronic inflammation of the pancreas has been uncovered. The pathogenic immune response that is common for both autoimmune pancreatitis and chronic pancreatitis was elucidated for the first time in the world. Applications are expected for new treatments of chronic pancreatic inflammation and new preventive measures for pancreatic cancer.
Permeation Mechanism of Water through Polymeric Membrane; Clarified for the First Time in the World Expectations for Development of Membranes with Functions, Such As Seawater Desalination - Kindai University
Press Releases • Oct 14, 2018 23:00 GMT
Associate Professor Noriyoshi Arai and his research group at the Mechanical Engineering Department at the Faculty of Science and Engineering of Kindai University have elucidated the mechanism of permeation through polymeric membranes. The findings of this research will be featured in the Journal of Membrane Science , on October 15, 2018 at 8:00 AM (JST).
Successful Use of AI Technology for Efficient Prediction of Physical Properties of Substances with Complex Molecular Structures
Press Releases • Sep 14, 2018 23:00 GMT
- The study demonstrated that machine learning can be applied to predict physical properties of functional materials that have complex structures. - For the first time in the world, machine learning methodology has been applied to the analysis of complex molecular structures of surfactants that are used in our immediate surroundings, such as detergents and cosmetic products.
Press Releases • Aug 24, 2018 14:00 GMT
1.Experiments have shown that the luminol reaction can be used to detect FOB in animals. 2.This is the first standard method to detect FOB in animal models for ulcers and cancers in the digestive system - which is simple, quick, economical and quantitative - making it applicable to use for any research laboratories.
World’s First Demonstration on Efficacy of Drug for Lung Cancer Genetic Mutation Diagnosed with Blood sample using cobas EGFR mutation test v2.Alleviating burden on patients through diagnosis with blood tests
Press Releases • Jul 31, 2018 07:09 GMT
[Key aspects of this study] - World’s first research findings that demonstrate efficacy and safety of a drug which is administered based on genetic screening results. - Efficacy demonstrated by a response rate of 55.1%, which represents the ratio of people whose tumor shrunk. - Potential for partial transition to blood test from endoscopic biopsy, which places a heavy burden on patients.